| 1 |
35259661 | Design and various in silico studies of the novel curcumin derivatives as potential candidates against COVID-19 -associated main enzymes. | 2022 Jun |
2 |
| 2 |
35508082 | Curcumin inhibits spike protein of new SARS-CoV-2 variant of concern (VOC) Omicron, an in silico study. | 2022 Apr 27 |
3 |
| 3 |
33397223 | Virtual screening of curcumin and its analogs against the spike surface glycoprotein of SARS-CoV-2 and SARS-CoV. | 2021 Jan 5 |
3 |
| 4 |
33479401 | Catechin and curcumin interact with S protein of SARS-CoV2 and ACE2 of human cell membrane: insights from computational studies. | 2021 Jan 21 |
6 |
| 5 |
33850236 | Author Correction: Catechin and curcumin interact with S protein of SARS-CoV2 and ACE2 of human cell membrane: insights from computational studies. | 2021 Apr 13 |
1 |
| 6 |
34138966 | Phenolic compounds disrupt spike-mediated receptor-binding and entry of SARS-CoV-2 pseudo-virions. | 2021 |
1 |
| 7 |
34481181 | In silico study of some selective phytochemicals against a hypothetical SARS-CoV-2 spike RBD using molecular docking tools. | 2021 Oct |
4 |
| 8 |
34574194 | Consumption of Phenolic-Rich Food and Dietary Supplements as a Key Tool in SARS-CoV-19 Infection. | 2021 Sep 3 |
1 |
| 9 |
33149560 | Targeting the GRP78-Dependant SARS-CoV-2 Cell Entry by Peptides and Small Molecules. | 2020 |
1 |